LeonaBio (LONA) Cash from Investing Activities (2019 - 2026)

LeonaBio (LONA) has 8 years of Cash from Investing Activities data on file, last reported at -$15.5 million in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$15.5 million, down 111.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$24.1 million (down 169.93% YoY), and the FY2025 annual result was -$15.9 million, down 128.99% from the prior year.
• Cash from Investing Activities retreated to -$15.5 million in Q1 2026 per LONA's latest filing, from -$14.6 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $35.5 million in Q1 2023 and troughed at -$15.5 million in Q1 2026.
• A 5-year average of $10.4 million and a median of $13.0 million in 2024 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities jumped 828.22% in 2023, then tumbled 420.55% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at $24.6 million in 2022, then tumbled by 74.07% to $6.4 million in 2023, then plunged by 144.0% to -$2.8 million in 2024, then plunged by 420.55% to -$14.6 million in 2025, then decreased by 6.16% to -$15.5 million in 2026.
• Business Quant data shows LONA's Cash from Investing Activities at -$15.5 million in Q1 2026, -$14.6 million in Q4 2025, and $5.7 million in Q3 2025.